Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma

© 2016 Gao et al.Background: Brain-expressed X-linked (BEX) 4 is a member of BEX family. The functional role of BEX4 in oral squamous cell carcinoma (OSCC) remains unknown. Methods: Expression level of BEX family members (BEX1-5) in OSCC tissues and the paired normal epithelial were examined. Functions of epigenetic changes (DNA methylation and histone modifications) on BEX4 suppression in OSCC were examined by zebularine and trichostatin A (TSA) treatment on OSCC cell lines. Lentivector containing full-length BEX4 was used to generate OSCC cell lines with stable BEX4 expression. Effects of BEX4 expression on OSCC proliferation were monitored with xCELLigence RTCA real-time cell analyzer. BEX4-overexpressing CAL27 was implanted into nude mice to evaluate the effects on tumor growth in vivo. The signaling pathways regulated by BEX4 in OSCC was explored using human whole-transcript expression microarray. Results: Among the 5 BEX family members, BEX1 and BEX4 showed significant down-regulation in OSCC (P < 0.001). BEX3, in comparison, was overexpressed in the primary tumor. BEX4 expression in OSCC cell lines was re-activated after zebularine and TSA treatment. High BEX4 expression could suppress proliferation of OSCC in vitro. Subcutaneous tumor volume of BEX4-overexpressing CAL27 was remarkably reduced in nude mice. Microarray experiment showed that S100A family members (S100A7, S100A7A, S100A8, S100A9 & S100A12) might be the downstream targets of BEX4 in OSCC. Conclusions: BEX4 functions as tumor suppressor by inhibiting proliferation and growth of oral cancer. Decreased BEX4 contributes to the increased proliferative propensity of OSCC.published_or_final_versio

ESL Club & Women Speak: Our Home Away From Home

SWOSU ESL Club Newsletter: Spring 2018 is the fourth issue of the newsletter for the English as a Second Language & Women Speak Club (ESL). Sponsors:Thanges KesnanFred Alsberg Editors:Fred AlsbergShannon MarcarArpana James Newsletter Crew:Oscar Cuellar Yun Hsuan LiaoYi Ling ChiaoJuo Chu Wuhttps://dc.swosu.edu/esl/1003/thumbnail.jp

Search for dark matter produced in association with bottom or top quarks in √s = 13 TeV pp collisions with the ATLAS detector

A search for weakly interacting massive particle dark matter produced in association with bottom or top quarks is presented. Final states containing third-generation quarks and miss- ing transverse momentum are considered. The analysis uses 36.1 fb−1 of proton–proton collision data recorded by the ATLAS experiment at √s = 13 TeV in 2015 and 2016. No significant excess of events above the estimated backgrounds is observed. The results are in- terpreted in the framework of simplified models of spin-0 dark-matter mediators. For colour- neutral spin-0 mediators produced in association with top quarks and decaying into a pair of dark-matter particles, mediator masses below 50 GeV are excluded assuming a dark-matter candidate mass of 1 GeV and unitary couplings. For scalar and pseudoscalar mediators produced in association with bottom quarks, the search sets limits on the production cross- section of 300 times the predicted rate for mediators with masses between 10 and 50 GeV and assuming a dark-matter mass of 1 GeV and unitary coupling. Constraints on colour- charged scalar simplified models are also presented. Assuming a dark-matter particle mass of 35 GeV, mediator particles with mass below 1.1 TeV are excluded for couplings yielding a dark-matter relic density consistent with measurements

Isolation of quorum quenching bacteria for biofouling control

[[notice]]補正完

Isolation of Bacteria Capable of Degrading Various AHLs for Biofouling Control in Membrane Bioreactors

Membrane bioreactors (MBRs) are widely used to treat wastewater, mainly due to the production of high-quality effluent. However, biofilm forming on the surface of membranes can cause many problems, which remains one of the major limitations of this technique. Bacterial quorum quenching (QQ) has been proven to be a successful strategy to control biofouling in MBRs. However, for many QQ bacterial isolates, the detailed degradation rates of acyl homoserine lactones (AHLs) have rarely been reported. Therefore, this study aimed to isolate potential QQ bacteria and investigate their degradation rates against eight different AHLs. Results showed that four isolates (A9, A12, B11, and D3) exhibited consistent C8-HSL&ndash;(N-octanoyl-L-homoserine lactone) removal capabilities. These four isolates removed at least 70% of all AHLs tested within 180 min. They might have different QQ enzymes, based on our observation that the locations of enzyme activities differed. The bacteria most closely related to A9, A12, and B11 were Brucella anthropic, Bacillus cereus, and Bacillus toyonensis, respectively. Bacillus species have shown QQ activity in many studies, but AHL-reducing Brucella species have not been previously reported. Overall, this study extends our current knowledge of QQ bacteria that could be used to mitigate biofilm formation on MBR membranes

Isolation of Bacteria Capable of Degrading Various AHLs for Biofouling Control in Membrane Bioreactors

Membrane bioreactors (MBRs) are widely used to treat wastewater, mainly due to the production of high-quality effluent. However, biofilm forming on the surface of membranes can cause many problems, which remains one of the major limitations of this technique. Bacterial quorum quenching (QQ) has been proven to be a successful strategy to control biofouling in MBRs. However, for many QQ bacterial isolates, the detailed degradation rates of acyl homoserine lactones (AHLs) have rarely been reported. Therefore, this study aimed to isolate potential QQ bacteria and investigate their degradation rates against eight different AHLs. Results showed that four isolates (A9, A12, B11, and D3) exhibited consistent C8-HSL–(N-octanoyl-L-homoserine lactone) removal capabilities. These four isolates removed at least 70% of all AHLs tested within 180 min. They might have different QQ enzymes, based on our observation that the locations of enzyme activities differed. The bacteria most closely related to A9, A12, and B11 were Brucella anthropic, Bacillus cereus, and Bacillus toyonensis, respectively. Bacillus species have shown QQ activity in many studies, but AHL-reducing Brucella species have not been previously reported. Overall, this study extends our current knowledge of QQ bacteria that could be used to mitigate biofilm formation on MBR membranes

Thermosensitive Polyester Hydrogel for Application of Immunosuppressive Drug Delivery System in Skin Allograft

Tacrolimus (FK506) is a common immunosuppressive drug that is capable of suppressing acute rejection reactions, and is used to treat patients after allotransplantation. A stable and suitable serum concentration of tacrolimus is desirable for better therapeutic effects. However, daily drug administration via oral or injection routes is quite inconvenient and may encounter drug overdose or low patient compliance problems. In this research, our objective was to develop an extended delivery system using a thermosensitive hydrogel of poly ethylene glycol, D,L-lactide (L), and ϵ-caprolactone (CL) block copolymer, mPEG-PLCL, as a drug depot. The formulation of mPEG-PLCL and 0.5% PVP-dissolved tacrolimus was studied and the optimal formulation was obtained. The in vivo data showed that in situ gelling is achieved, a stable and sustained release of the drug within 30 days can be maintained, and the hydrogel was majorly degraded in that period. Moreover, improved allograft survival was achieved. Together, these data imply the potential of the current formulation for immunosuppressive treatments

Downregulation of the DNA Repair Gene DDB2 by Arecoline Is through p53’s DNA-Binding Domain and Is Correlated with Poor Outcome of Head and Neck Cancer Patients with Betel Quid Consumption

Arecoline is the principal alkaloid in the areca nut, a component of betel quids (BQs), which are carcinogenic to humans. Epidemiological studies indicate that BQ-chewing contributes to the occurrence of head and neck cancer (HNC). Previously, we have reported that arecoline (0.3 mM) is able to inhibit DNA repair in a p53-dependent pathway, but the underlying mechanism is unclear. Here we demonstrated that arecoline suppressed the expression of DDB2, which is transcriptionally regulated by p53 and is required for nucleotide excision repair (NER). Ectopic expression of DDB2 restored NER activity in arecoline-treated cells, suggesting that DDB2 downregulation was critical for arecoline-mediated NER inhibition. Mechanistically, arecoline inhibited p53-induced DDB2 promoter activity through the DNA-binding but not the transactivation domain of p53. Both NER and DDB2 promoter activities declined in the chronic arecoline-exposed cells, which were consistent with the downregulated DDB2 mRNA in BQ-associated HNC specimens, but not in those of The Cancer Genome Atlas (TCGA) cohort (no BQ exposure). Lower DDB2 mRNA expression was correlated with a poor outcome in HNC patients. These data uncover one of mechanisms underlying arecoline-mediated carcinogenicity through inhibiting p53-regulated DDB2 expression and DNA repair

In Vitro Characterization of Neutralizing Hen Antibodies to Coxsackievirus A16

Coxsackievirus A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease (HFMD). Children aged &lt;5 years are the most affected by CA16 HFMD globally. Although clinical symptoms of CA16 infections are usually mild, severe complications, such as aseptic meningitis or even death, have been recorded. Currently, no vaccine or antiviral therapy for CA16 infection exists. Single-chain variable fragment (scFv) antibodies significantly inhibit viral infection and could be a potential treatment for controlling the infection. In this study, scFv phage display libraries were constructed from splenocytes of a laying hen immunized with CA16-infected lysate. The pComb3X vector containing the scFv genes was introduced into ER2738 Escherichia coli and rescued by helper phages to express scFv molecules. After screening with five cycles of bio-panning, an effective scFv antibody showing favorable binding activity to proteins in CA16-infected lysate on ELISA plates was selected. Importantly, the selected scFv clone showed a neutralizing capability against the CA16 virus and cross-reacted with viral proteins in EV71-infected lysate. Intriguingly, polyclonal IgY antibody not only showed binding specificity against proteins in CA16-infected lysate but also showed significant neutralization activities. Nevertheless, IgY-binding protein did not cross-react with proteins in EV71-infected lysate. These results suggest that the IgY- and scFv-binding protein antibodies provide protection against CA16 viral infection in in vitro assays and may be potential candidates for treating CA16 infection in vulnerable young children